S&P 500 7,650.50 +0.17%
Nasdaq 26,522.55 +0.39%
S&P/TSX 35,806.65 −0.19%
Apple 336.13 −0.26%
Nvidia 222.27 +1.34%
Microsoft 493.78 −0.80%
Shopify 179.34 −0.37%
Royal Bank 284.45 −0.17%
CAD/USD 0.7149 +0.02%
CLOSED · 05:05 ET
Market ClerkRecap
Sun Sep 20 · markets closed2 signals on Sep 19263 insider buys this week · $115.4MCIRO short report next: Sep 30The week ahead
SK
INSIDER · WGS · GeneDx Holdings Corp. · CHIEF EXECUTIVE OFFICER

Stueland Katherine

Every open-market transaction filed under this name, Sep 9 to Sep 16.

Filings
6
0 buys · 6 sells
Bought
open market, at cost
Sold
$1.3M
includes scheduled sales
Buys since
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 16WGSGeneDx Holdings Corp.CHIEF EXECUTIVE OFFICERSell3,039$99.00$301K−9.3%
Sep 16WGSGeneDx Holdings Corp.CHIEF EXECUTIVE OFFICERSell4,141$98.27$407K−8.7%
Sep 16WGSGeneDx Holdings Corp.CHIEF EXECUTIVE OFFICERSell1,525$96.90$148K−7.4%
Sep 16WGSGeneDx Holdings Corp.CHIEF EXECUTIVE OFFICERSell148$95.41$14K−5.9%
Sep 16WGSGeneDx Holdings Corp.CHIEF EXECUTIVE OFFICERSell1,648$94.26$155K−4.8%
Sep 9WGSGeneDx Holdings Corp.CHIEF EXECUTIVE OFFICERSell3,692$84.22$311K+6.6%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.